HMGB1 and idiopathic pulmonary fibrosis: Abe et al. [18, 19] showed that PMX-DHP treatment eliminated activated neutrophils and humoral factors, including matrix metalloproteinase-9 and HMGB-1, which are relevant to an improved P/F ratio, from the blood circulation in patients with acute exacerbations of IPF.